{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:15Z","timestamp":1790395275171,"version":"4.1.0"},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,9,25]]},"DOI":"10.1253\/circj.cj-26-0325","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:11:17Z","timestamp":1787177477000},"page":"1336-1347","source":"Crossref","is-referenced-by-count":1,"title":["Low Body Weight and Long-Term Outcomes in Cancer-Associated Venous Thromboembolism\u3000\u2015 From the COMMAND VTE Registry-2 \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Soichiro","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Hyogo College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Chatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kurashiki Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Kaneda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Toyonaka Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Center, Osaka Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Center, Medical Research Institute Kitano Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takase","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Wakayama Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Oi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Otsu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Takada","sequence":"additional","affiliation":[{"name":"Institute of Advanced Biomedical Engineering and Science\/Department of Cardiology, Tokyo Women\u2019s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Otsui","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tenri Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shiga General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Usami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kansai Electric Power Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Saiseikai Noe Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Togi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nara Hospital, Kindai University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimichi","family":"Koitabashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Hiramori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Koto Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimada General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shizuoka City Shizuoka Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takabayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hirakata Kohsai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Sugita Genpaku Memorial Obama Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sueta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shioyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Dohke","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kohka Public Hospita"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hirakata Kohsai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COMMAND VTE Registry-2 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. <i>Thromb Haemost<\/i> 2017; 117: 219\u2013230.","DOI":"10.1160\/TH16-08-0615"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, et al. Newly diagnosed cancer after diagnosis of venous thromboembolism: Insights from the COMMAND VTE Registry-2. <i>Circ J<\/i> 2026; 90: 410\u2013417.","DOI":"10.1253\/circj.CJ-24-0786"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M; RIETE Investigators. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. <i>Thromb Res<\/i> 2013; 131: 24\u201330.","DOI":"10.1016\/j.thromres.2012.10.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. <i>Blood<\/i> 2002; 100: 3484\u20133488.","DOI":"10.1182\/blood-2002-01-0108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Monreal M, Falga C, Valdes M, Suarez C, Gabriel F, Tolosa C, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE registry. <i>J Thromb Haemost<\/i> 2006; 4: 1950\u20131956.","DOI":"10.1111\/j.1538-7836.2006.02082.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ikeda S, Yamashita Y, Morimoto T, Ueno Y, Maemura K, Chatani R, et al. Prediction score for major bleeding in patients with venous thromboembolism receiving direct oral anticoagulants: Insights from the COMMAND VTE Registry-2. <i>Circ J<\/i> 2025; 89: 1896\u20131905.","DOI":"10.1253\/circj.CJ-25-0186"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. <i>N Engl J Med<\/i> 2018; 378: 615\u2013624.","DOI":"10.1056\/NEJMoa1711948"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, et al. Comparison of an oral Factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D). <i>J Clin Oncol<\/i> 2018; 36: 2017\u20132023.","DOI":"10.1200\/JCO.2018.78.8034"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Agnelli G, Becattini C, Meyer G, Munoz A, Huisman MV, Connors JM, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. <i>N Engl J Med<\/i> 2020; 382: 1599\u20131607.","DOI":"10.1056\/NEJMoa1915103"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barba R, Marco J, Martin-Alvarez H, Rondon P, Fernandez-Capitan C, Garcia-Bragado F, et al. The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: Findings from a prospective registry (RIETE). <i>J Thromb Haemost<\/i> 2005; 3: 856\u2013862.","DOI":"10.1111\/j.1538-7836.2005.01304.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kaneda K, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, et al. Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry. <i>Thromb Res<\/i> 2021; 198: 26\u201333.","DOI":"10.1016\/j.thromres.2020.11.022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Upreti VV, Wang J, Barrett YC, Byon W, Boyd RA, Pursley J, et al. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. <i>Br J Clin Pharmacol<\/i> 2013; 76: 908\u2013916.","DOI":"10.1111\/bcp.12114"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kubitza D, Becka M, Zuehlsdorf M, Mueck W. Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects. <i>J Clin Pharmacol<\/i> 2007; 47: 218\u2013226.","DOI":"10.1177\/0091270006296058"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Verhamme P, Wells PS, Segers A, Ageno W, Brekelmans MP, Cohen AT, et al. Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial. <i>Thromb Haemost<\/i> 2016; 116: 747\u2013753.","DOI":"10.1160\/TH16-03-0244"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Kobayashi S, Ogihara Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, et al. Low body weight and long-term outcomes in patients with venous thromboembolism: Insights from the COMMAND VTE Registry-2. <i>Thromb Haemost<\/i> 2025, doi:10.1055\/a-2760-8218.","DOI":"10.1055\/a-2760-8218"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, et al. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants. <i>Eur J Intern Med<\/i> 2023; 118: 59\u201372.","DOI":"10.1016\/j.ejim.2023.08.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2013; 369: 2093\u20132104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 981\u2013992.","DOI":"10.1056\/NEJMoa1107039"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, et al. Cancer-associated venous thromboembolism in the real world: From the COMMAND VTE Registry. <i>Circ J<\/i> 2019; 83: 2271\u20132281.","DOI":"10.1253\/circj.CJ-19-0515"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nishimoto Y, Yamashita Y, Kim K, Morimoto T, Saga S, Amano H, et al. Risk factors for major bleeding during anticoagulation therapy in cancer-associated venous thromboembolism: From the COMMAND VTE Registry. <i>Circ J<\/i> 2020; 84: 2006\u20132014.","DOI":"10.1253\/circj.CJ-20-0223"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Faller N, Limacher A, Mean M, Righini M, Aschwanden M, Beer JH, et al. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: A prospective cohort study. <i>Am J Med<\/i> 2017; 130: 198\u2013206.","DOI":"10.1016\/j.amjmed.2016.09.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. <i>J Thromb Haemost<\/i> 2005; 3: 692\u2013694.","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Hokusai VTEI, Buller HR, Decousus H, Grosso MA, Mercuri M, Middeldorp S, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. <i>N Engl J Med<\/i> 2013; 369: 1406\u20131415, doi:10.1056\/NEJMoa1306638.","DOI":"10.1056\/NEJMoa1306638"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. <i>J Am Stat Assoc<\/i> 1999; 94: 496\u2013509.","DOI":"10.1080\/01621459.1999.10474144"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, et al. Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. <i>Eur J Vasc Endovasc Surg<\/i> 2021; 61: 9\u201382.","DOI":"10.1016\/j.ejvs.2020.09.023"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, et al. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. <i>J Thromb Haemost<\/i> 2022; 20: 1910\u20131919.","DOI":"10.1111\/jth.15776"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). <i>Eur Heart J<\/i> 2020; 41: 543\u2013603.","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. <i>Chest<\/i> 2012; 141: e419S\u2013e496S.","DOI":"10.1378\/chest.11-2301"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, et al. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism. <i>Eur J Intern Med<\/i> 2024; 127: 74\u201383.","DOI":"10.1016\/j.ejim.2024.04.012"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Harrell FE Jr. Regression modeling strategies: With applications to linear models, logistic and ordinal regression, and survival analysis, 2nd edn. Springer, 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"key":"31","unstructured":"31. Mahe I, Chapelle C, Girard P, Carrier M, Palomares LJ, Samama CM, et al. Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): A post-hoc analysis of a randomised, non-inferiority trial. <i>Lancet Haematol<\/i> 2026; 13: e41\u2013e48."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sato T, Ogihara Y, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, et al. Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial. <i>Thromb Res<\/i> 2026; 259: 109631.","DOI":"10.1016\/j.thromres.2026.109631"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Chatani R, Yamashita Y, Morimoto T, Kaneda K, Mushiake K, Kadota K, et al. Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era. <i>Eur J Intern Med<\/i> 2024; 123: 72\u201380.","DOI":"10.1016\/j.ejim.2024.01.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kim K, Yamashita Y, Morimoto T, Kitai T, Yamane T, Ehara N, et al. Risk factors for major bleeding during prolonged anticoagulation therapy in patients with venous thromboembolism: From the COMMAND VTE Registry. <i>Thromb Haemost<\/i> 2019; 119: 1498\u20131507.","DOI":"10.1055\/s-0039-1692425"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Klok FA, Hosel V, Clemens A, Yollo WD, Tilke C, Schulman S, et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. <i>Eur Respir J<\/i> 2016; 48: 1369\u20131376.","DOI":"10.1183\/13993003.00280-2016"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE disease: Second update of the CHEST Guideline and Expert Panel report. <i>Chest<\/i> 2021; 160: e545\u2013e608.","DOI":"10.1016\/j.chest.2021.07.055"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. <i>Nat Rev Dis Primers<\/i> 2018; 4: 17105.","DOI":"10.1038\/nrdp.2017.105"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0325\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:28:11Z","timestamp":1790393291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/10\/90_CJ-26-0325\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0325","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"CJ-26-0325"}}